Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
ENDPOINTS
editor@endpointsnews.com
author articles
Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tablet
4 months ago
News Briefing
IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic
4 months ago
News Briefing
Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal
5 months ago
News Briefing
AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s
5 months ago
News Briefing
Turnstone stops TIL studies; GH Research’s $150M offering
5 months ago
News Briefing
Tectonic to raise $185M; Acelyrin drops rights to Affibody drug
5 months ago
News Briefing
Ironwood's layoffs; Shionogi’s RSV pill succeeds in Phase 2
5 months ago
News Briefing
Curie.Bio has a new $340M fund; Layoffs at Benchling, I-Mab
5 months ago
News Briefing
Key GOP senator is ‘struggling’ with Kennedy nomination over vaccine answers
5 months ago
People
Pharma
Trump blog: Federal agencies must give jobs back to fired probationary workers, judge rules
5 months ago
Pharma
FDA+
Boehringer merges cancer vaccine and oncolytic virus teams; Dantari sells off assets
5 months ago
News Briefing
FDA delays decision on Stealth’s Barth syndrome drug; TargetRx raises $50M
5 months ago
News Briefing
Shanghai Bao, Sichuan Biokin file IPOs in Hong Kong; Disc's $200M offering
5 months ago
News Briefing
FDA puts Atara’s INDs on hold after rejection; Ascletis' safety data for obesity pill
5 months ago
News Briefing
WuXi AppTec sells medical device testing unit; Layoffs at Notch Therapeutics
5 months ago
News Briefing
Boehringer's schizophrenia asset fails Phase 3; GSK buys organoid biotech
5 months ago
News Briefing
Hinge Bio's $30M raise; Keros reports additional issues in Phase 2 PAH trial
5 months ago
News Briefing
#JPM25 live blog day 3: PhRMA chief on reforming the IRA; Gilead weighs in on China dealmaking
5 months ago
Pharma
Regeneron, Illumina invest in Truveta; Inhibrx Bio’s $150M loan
5 months ago
News Briefing
#JPM25 live blog day 2: Nvidia makes it fun; The year's 10th megaround
5 months ago
Pharma
Immunovant’s $450M private placement; Biomea becomes an obesity biotech
5 months ago
News Briefing
#JPM25 live blog day 1: How will Trump 2.0 impact the biopharma industry? Scott Gottlieb, Bob Nelsen share ...
5 months ago
Deals
Pharma
Stemson Therapeutics shutters; Insilico teams up again with Menarini
6 months ago
News Briefing
Numab extends its Series C; AnaCardio raises $19M for its heart failure drug
6 months ago
News Briefing
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page